Share on StockTwits

Medical ethicists will get together to talk about a sensitive question arising from the Ebola outbreak in West Africa: Who should have access to extremely limited supplies of experimental medicine? Two American aid workers who contracted Ebola got better after they were given an experimental drug, which was never before tried on humans. But the manufacturer has said it can’t make large quantities of the drug, although others are in development. There is no certified vaccine or cure for Ebola.

“Who Should Get Experimental Ebola Medicine?” is categorized as “world”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.